参考文献/References:
［1］谢幸，苟文丽.妇产科学 ［M］.第8版.北京：人民卫生出版社，2013：48-49.
［2］JONATHAN S.精［M］.第14版.北京：人民卫生出版社，2008：380-381.
［3］HA Wa ha-bi, FAYED A A, et al.Progestogen for treating threatened miscarriage［J］.The Cochrane Database of Systematic Reviews, 2011(12): CD005943.
［4］YEKO T R, GORRILL M J, et al.Timely diagnosis of early ectopic pregnancy using a single blood progesterone measurement［J］.Fertility&Sterility, 1987, 48(6): 1048-1050.
［5］MCCORD M L, MURAM D, et al.Single serum progesterone as a screen for ectopic pregnancy:exchanging specificity and sensitivity to obtain optimal test performance ［J］.Fertility&Sterility, 1996, 66(4): 513-516.
［6］OSMANAGAOGLU M A, ERDOGAN I, et al.The diagnostic value of beta-human chorionic gonadotropin,progesterone,CA125 in the prediction of abortions ［J］.Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology, 2010, 30(3): 288-293.
［7］Abdelazim IA,elezz AA,elsherbiny M.relation between single serum progesterone assay and viability of the first trimester pregnancy ［J］.SpringerPlus, 2012, 1(1): 80.
［8］UGURLU E N, OZAKSIT G, et al.The value of vascular endothelial growth factor,pregnancy-associated plasma protein-A,and progesterone for early differentiation of ectopic pregnancies,normal intrauterine pregnancies,and spontaneous miscarriages ［J］.Fertility and Sterility, 2009, 91(5): 1657-1661.
［9］樊晓然.血清β-HCG及孕酮检测在先兆流产的临床应用 ［J］.实用临床医药杂志，2014，18（3）：113-115.
［10］MARTINEZ-RUIZ A, SARABIA-MESEGUER M D, et al.Placental growth factor,soluble fms-like tyrosine kinase 1 and progesterone as diagnostic biomarkers for ectopic pregnancy and missed abortion ［J］.Clinical Biochemistry, 2014, 47(9): 844-847.
［11］Hanita O,hanisah AH.potential use of single measurement of serum progesterone in detecting early pregnancy failure ［J］.The Malaysian Journal of Pathology, 2012, 34(1): 41-46.
［12］Hoffman B.L. 威廉姆斯妇科学［M］.北京：科学出版社，2011：143.
［13］自然流产 ［M］.北京：人民卫生出版社，2015.
［14］STANCZYK F Z, HAPGOOD J P, et al.Progestogens used in postmenopausal hormone therapy:differences in their pharmacological properties,intracellular actions,and clinical effects［J］.Endocrine Reviews, 2013, 34(2): 171-208.
［15］FDA. Advisory Committee Calendar - August 13, 2009: Reproductive Health Drugs Advisory Committee Meeting Announcement ［J］.
［16］FDA.hydroxyprogesterone caproate injection for intramuscular use label［EBOL］.www.accessdata.fda.gov/drugsatfda_docs/label/2011/021945s000lbl.pdf.2011-02-04/2017/8/8.
［17］Recurrent pregnancy loss:causes,controversies,and treatment,second edition ［M］.new york: crc press, 2015.
［18］臧美春,林森,姜天华.黄体酮不良反应文献概述 ［J］.中国药物滥用防治杂志，2014，20 （1）：44-45.
［19］魏臻,孙骏.黄体酮注射液事件引起的安全用药思考 ［J］.中国药房，2016，27（13）：1749-1751.
［20］CARMICHAEL S L, SHAW G M, et al.Maternal progestin intake and risk of hypospadias［J］.Archives of Pediatrics & Adolescent Medicine, 2005, 159(10): 957-962.
［21］郑婷萍,薛薇,孙爱军.孕酮用于早孕保胎治疗相关研究进展［J］.中国实用妇科与产科杂志，2012,28（9）：709-712.
［22］SIMONCINI T, CARUSO A, et al.Effects of dydrogesterone and of its stable metabolite,20-alpha-dihydrodydrogesterone,on nitric oxide synthesis in human endothelial cells［J］.Fertility and Sterility, 2006, 86(4 Suppl): 1235-1242.
［23］COOMARASAMY A, WILLIAMS H, et al.A randomized trial of progesterone in women with recurrent miscarriages［J］.New England Journal of Medicine, 2015, 373(22): 2141-2148.
［24］KUMAR A, BEGUM N, et al.Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production:a double-blind,randomized,parallel,placebo-controlled trial［J］.Fertility and Sterility, 2014, 102(5): 1357-1363.
［25］King R J,whitehead M I.assessment of the potency of orally administered progestins in women［J］.Fertility&Sterility, 1986, 46(6): 1062-1066.
［26］张扬,俞美娟.地屈孕酮与黄体酮用于治疗先兆流产的临床效果比较 ［J］.生殖医学杂志，2014，23（11）：880-883.
［27］Siew S, Yan H C, Tan T C, et al.Micronized Progesterone Compared With Dydrogesterone for Threatened Miscarriage: A Randomized Controlled Trial ［J］.Obstetrics & Gynecology, 2015, 125 （Suppl 1）:104S
［28］Haas D M,ramsey P S.progestogen for preventing miscarriage ［J］.Cochrane Database of Systematic Reviews, 2013, 10(2): CD003511.
［29］Howard Carp.A systematic review of dydrogesterone for the treatment of recurrent miscarriage［J］.Gynecological Endocrinology, 2015, 316:1-9.
［30］National collaborating centre for women's and children's health(UK)ectopic pregnancy and miscarriage:diagnosis and initial management in early pregnancy of ectopic pregnancy and miscarriage ［J］.Rcog, 2012, 1(4): 21-28.
［31］Coomarasamy a,truchanowicz E G,Rai R.Does first trimester progesterone prophylaxis increase the live birth rate in women with unexplained recurrent miscarriages?［J］.Bmj British Medical Journal, 2011, 342(7803): 922-923.
［32］SCHINDLER A E, CARP H, et al.European progestin club guidelines for prevention and treatment of threatened or recurrent(habitual)miscarriage with progestogens［J］.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology, 2015, 31(6): 447.
［33］ACOG,Early Pregnancy Loss2015［J］.Obstetrics & Gynecology, 2015, 125(5):1258-1267.
［34］孙贇，刘平，叶虹，等.黄体支持与孕激素补充共识 ［J］.生殖与避孕，2015，35（1）：1-8.
［35］陈子江，林其德，王谢桐，等.孕激素维持早期妊娠及防治流产的中国专家共识 ［J］.中华妇产科杂志，2016，51（7）：481-483.
［36］康岳华,张宝云,王凭青,等.孕酮受体介导哺乳动物雌性生殖活动的分子机理 ［J］.遗传,2012,34(10):1223-1232..
［37］刘颖综述,谢梅青审校.孕激素受体发挥作用的机制及其调控因素 ［J］.国际妇产科学杂志，2012，39 （6）：570-573.
［38］XIN Qi-liang, QIU Jing-tao, et al.Transcriptional activation of nuclear estrogen receptor and progesterone eceptor and its regulation［J］.Acta Physiologica Sinica, 2016, 68(4): 435-454.
［39］Preisler J, Kopeika J, Ismail L, et al.Defining safe criteria to diagnose miscarriage: prospective observational multicentre study［J］.BMJ, 2015, 351:h4579.
［40］Filicori M,butler J P,Jr C W.neuroendocrine regulation of the corpus luteum in the human evidence for pulsatile progesterone secretion ［J］.Journal of Clinical Investigation, 1984, 73(4): 1638-1647.
相似文献/References:
[1]张以文.绝经期激素治疗中不同孕激素制剂的比较[J].中国计划生育和妇产科,2012,(05):0.
ZHANG Yi-wen.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(11):0.
[2]何玉萍,孙家玉,李晋平,等.雌激素配伍孕激素在吸宫术后预防宫腔粘连的作用[J].中国计划生育和妇产科,2014,(07):0.
HE Yu-ping,SUN Jia-yu,LI Jin-Ping,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(11):0.
[3]王丽娜,陈映婷.封闭抗体阴性的早期流产患者使用被动免疫治疗的效果观察[J].中国计划生育和妇产科,2015,(08):0.
WANG Li-na,CHEN Ying-ting,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(11):0.
[4]那晶,汤小晗,李萌,等.卵泡中肝素结合表皮生长因子的表达与卵泡发育及雌孕激素水平的关系[J].中国计划生育和妇产科,2015,(12):0.
NA Jing,TANG Xiao-han,LI Meng,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2015,(11):0.
[5]赵楠,张萍*.子宫内膜不典型增生患者保留生育功能的相关研究进展[J].中国计划生育和妇产科,2017,(9):15.
[6]陈静,刘彩霞*.双胎妊娠抗早产临床预测及措施[J].中国计划生育和妇产科,2018,(11):15.
[7]周怀君.子宫内膜息肉的药物治疗新进展[J].中国计划生育和妇产科,2021,(7):33.[doi:10.3969/j.issn.1674-4020.2021.07.11]
[J].Chinese Journal of Family Planning & Gynecotokology,2021,(11):33.[doi:10.3969/j.issn.1674-4020.2021.07.11]